Payable Dec 26; for shareholders of record Dec 22; ex-div Dec 22. More on VanEck Biotech ETF SA Quant ranks Goldman's health ...
Zacks Investment Research on MSN
Is iShares Biotechnology ETF (IBB) a strong ETF right now?
A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market. What Are Smart Beta ETFs? The ...
After a strong biotech rebound, one fund quietly walked away from sector beta, and the timing says more than the trade itself.
24/7 Wall St. on MSN
2 Top Growth Themes Beyond AI and How to Invest in Them
The AI trade has been wobbling quite a bit in recent weeks, to say the least. And while the popping of the AI bubble hasn’t ...
Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these exchange-traded funds benefit from permanent relevance.
Biotech ETFs have had a banner year, earning some investors returns north of 30 percent since January. I say “some investors” because, it turns out, not all biotech ETFs are created equal. In our 2012 ...
Traders should base analysis on the underlying index (XBI), as LABU's price action is distorted by leverage-induced drift.
First, the Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU) seeks daily investment results, before fees and expenses, of 300% of the performance of the aforementioned biotech index. Second, the ...
The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the U.S. common stocks listed on the NYSE, AMEX, ...
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results